| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |